In New York, the Company successfully facilitated an advanced training initiative at the Columbia University Irving Medical Center, led by Dr. Jennifer Kuo, Director of the Interventional Endocrinology Program and Fellowship Director at Columbia University. This high-level collaboration empowered distinguished specialists Dr. Todd Frieze and Dr. Alberto Monreal from Duke Health, to refine techniques in minimally invasive therapies, including Baird Medical´s Microwave Ablation System for the treatment of Ben ...

The event featured a combination of expert-led didactic lectures and live case observations, providing participating physicians from across Asia with critical insights into clinical applications and techniques. By focusing on both theoretical knowledge and practical application, the Masterclass reinforced the importance of precision in clinical practice and facilitated the exchange of advanced methodology among regional specialists. This initiative highlights Baird Medical's enduring commitment to physicia ...

This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or Baird Medical's future financial or operating performance. In some cases, you can identify forward-looking statements by terminology such as "may", "could", "should", "expect", "intend", "might", "will", "estimate", "an ...

Core Insights - The company has successfully launched its product in Pakistan at the Armed Forces Institute of Radiology & Imaging, guided by Dr. Raza Raheem, a key figure in interventional radiology [1] - The registration approval in Vietnam signifies a major expansion of Baird Medical's presence in the Southeast Asian market, highlighting the company's commitment to global commercialization [2][3] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments [3] - The company aims to enhance patient outcomes through precision technology and advanced diagnostic solutions, and plans to collaborate with leading academic institutions [3] - Baird Medical is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals in the U.S., including Mayo Clinic and UCSF Medical Center [3] - The company is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries [3]

The decision to anchor production in North America is driven by the Company's rapid commercial success across over a dozen countries, including recent significant market penetrations in Indonesia and Malaysia. To support this international footprint, Baird Medical has partnered with California-based MPS Medical to create a centralized production hub. This facility is designed to supply Baird Medical's advanced proprietary technologies to global markets, ensuring the highest standards of quality and supply ...

Core Insights - The AAES Annual Meeting is a key event for endocrine surgeons in North America, focusing on advancements in endocrine surgery, particularly in thyroid diseases, parathyroid, adrenal glands, and endocrine pancreas [1] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments [5] - The company is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics across the United States, including Johns Hopkins Hospital and Columbia University Medical Center [5] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [5] Strategic Engagement - Baird Medical's participation in the AAES 2025 meeting emphasizes the importance of its MWA technology in minimally invasive treatments for endocrine conditions, especially thyroid nodules [2] - The company views the meeting as an opportunity to gain insights into surgical advancements and clinical trends, supporting its strategic initiatives and fostering collaborations [3] - Baird Medical aims to contribute to scientific exchange and advance patient care through technological innovation at the 2025 meeting in Milwaukee [4]

Core Insights - Baird Medical is focused on enhancing the accessibility and effectiveness of minimally invasive treatments for thyroid conditions through global partnerships and technological advancements [2][3] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, particularly in the development of AI-powered surgical robotic systems and innovative surgical instruments [3] - The company aims to improve patient outcomes by integrating advanced diagnostic solutions and precision technology [3] - Baird Medical is FDA 510(k)-certified and has deployed its solutions in over 30 prestigious hospitals and clinics across the United States, including notable institutions like Johns Hopkins Hospital and Weill Cornell Medicine [3] - The company is a market leader in China for thyroid microwave ablation devices and consumables, with a growing commercial presence in over 20 countries worldwide [3] Recent Developments - Dr. Tse's observations of thyroid nodule ablation procedures at Sun Yat-sen University Cancer Center provided insights into the clinical efficacy of Baird Medical's MWA system [1] - Academic discussions with Dr. Michael Mingzhao Xing at Johns Hopkins University highlighted the latest advancements in thyroid nodule management [1]

Using Baird Medical's MWA system for the first time, Dr. Kazeem praised its efficiency and seamless integration into clinical practice. "The system is both intuitive and optimizes procedure time, allowing treatments more streamlined without compromising patient outcomes," he stated. Baird Medical remains dedicated to driving innovation in medical technology and promoting the adoption of MWA among healthcare professionals worldwide. "Dr. Kazeem's successful experience highlights the value of our technology i ...

Core Insights - Baird Medical has received regulatory approval to expand its operations in Indonesia, emphasizing its commitment to enhancing patient care through innovative, minimally invasive technologies [1][3] - The company specializes in microwave ablation (MWA), a precise and effective procedure for treating conditions like thyroid nodules and tumors, known for its minimal impact on surrounding tissues and faster recovery times [2][4] - Baird Medical aims to strengthen its distribution network and collaborate with key medical institutions in Indonesia, reinforcing its strategy to introduce next-generation medical solutions to emerging markets [3][4] Company Overview - Baird Medical is a medical device company focused on minimally invasive diagnostics and treatments, dedicated to the research and development of AI-powered surgical robotic systems and innovative surgical instruments [4] - The company has deployed its solutions in over 30 prestigious hospitals and clinics in the United States, including renowned institutions like Johns Hopkins Hospital and Weill Cornell Medicine [4] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [4]

Core Insights - The training program for the delegation focused on enhancing expertise in microwave ablation (MWA) techniques, featuring both theoretical discussions and hands-on demonstrations [1][2] - Baird Medical emphasizes its commitment to global knowledge-sharing and medical innovation, aiming to advance MWA technology and improve patient care worldwide [3] - Baird Medical is a publicly traded company on NASDAQ, specializing in minimally invasive MWA technology for various medical conditions [4] Training Program Details - The first day of the program included theoretical discussions and hands-on demonstrations at Baird Medical's facility, providing a deeper understanding of MWA applications [1] - On the second day, the delegation observed live MWA procedures at Sun Yat-sen University Cancer Center and engaged in discussions with leading specialists [2] - The program concluded with an in-depth session on thyroid microwave ablation techniques, enhancing the participants' knowledge of the latest advancements in MWA technology [2] Company Overview - Baird Medical is a leader in providing advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer through MWA technology [4] - The company is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices [4]